NasdaqGS:ICLRLife Sciences
A Look At ICON (ICLR) Valuation After New Advarra Clinical Trial Network Partnership
ICON (NasdaqGS:ICLR) has drawn fresh attention after announcing a definitive partnership with Advarra to build a connected, research ready clinical trial site network that aims to simplify operations and widen trial access.
See our latest analysis for ICON.
Despite the Advarra agreement and recent conference appearances, ICON’s recent share price return has been mixed, with modest gains over the past month but a much weaker 90 day share price return of 44.9% and a 1 year total shareholder...